These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11462994)
1. Patient-initiated treatment of recurrent urinary tract infection in women. Ann Intern Med; 2001 Jul; 135(1):S18. PubMed ID: 11462994 [No Abstract] [Full Text] [Related]
2. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Gupta K; Hooton TM; Roberts PL; Stamm WE Ann Intern Med; 2001 Jul; 135(1):9-16. PubMed ID: 11434727 [TBL] [Abstract][Full Text] [Related]
3. 3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women. Raz R; Rozenfeld S Antimicrob Agents Chemother; 1996 Sep; 40(9):2200-1. PubMed ID: 8878607 [No Abstract] [Full Text] [Related]
4. Single dose of ofloxacin treatment in women with dysuria and frequency. Simşek F; Dillioğlugil O; Ilker Y; Akdaş A Int Urol Nephrol; 1993; 25(3):249-54. PubMed ID: 8225825 [TBL] [Abstract][Full Text] [Related]
5. [Clinical experience with the use of ofloxacin in infections of the upper and lower urinary tracts: demonstrations of the results of clinical trials]. Liudvig G Antibiot Khimioter; 1996; 41(9):84-5. PubMed ID: 9005795 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of levofloxacin (Tavanik, "Aventis Pharma") in the treatment of complicated infections of the urogenital organs]. Derevianko II; Lavrinova LN; Kudriashova EE Urologiia; 2003; (1):31-4. PubMed ID: 12621964 [No Abstract] [Full Text] [Related]
7. Usefulness and problems of the urinary tract infection criteria for evaluating drug efficacy for complicated urinary tract infections. Arakawa S; Tanaka K; Miura T; Shigemura K; Takenaka A; Matsui T; Kamidono S; Nakano Y; Fujisawa M J Infect Chemother; 2007 Oct; 13(5):279-84. PubMed ID: 17982714 [TBL] [Abstract][Full Text] [Related]
8. [Personal experience with ofloxacin in patients with resistant urinary tract infections]. Horácková M; Osten J; Potuzník V Vnitr Lek; 1988 Jun; 34(6):545-9. PubMed ID: 3166276 [No Abstract] [Full Text] [Related]
9. [Therapy of complicated urinary tract infections using ofloxacin--a 2d generation antibacterial quinolone]. Prát V; Horcicková M; Matousovic K; Hatala M; Janda P; Milotová Z Cas Lek Cesk; 1988 May; 127(19):586-8. PubMed ID: 3165054 [No Abstract] [Full Text] [Related]
10. Recurrent urinary tract infection in the female patient. Schaeffer AJ Urology; 1988 Sep; 32(3 Suppl):12-5. PubMed ID: 3047957 [No Abstract] [Full Text] [Related]
11. Evaluation and therapy of urinary tract infection: a critique. Soderdahl DW Hawaii Med J; 1986 Sep; 45(9):306-10. PubMed ID: 3771203 [No Abstract] [Full Text] [Related]
12. Ofloxacin vs. cotrimoxazole in patients with complicated urinary tract infections. Vellucci A; Bernardini G; Battaglia AM; Battaglia P Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):279-81. PubMed ID: 3496284 [TBL] [Abstract][Full Text] [Related]
13. Bacteriological conversion in twenty urinary tuberculosis patients treated with ofloxacin, rifampin and isoniazid: a 10-year follow-up study. Castiñeiras AA; Pérez-Pascual P; Zarranz JE; Della-Latta P; Herreras A Int Microbiol; 2002 Sep; 5(3):139-44. PubMed ID: 12207216 [TBL] [Abstract][Full Text] [Related]